Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease

Cell Chemical Biology

Volumn 23, Issue 1, 2016, Pages 158-172

  Shrestha, Liza ^a   Patel, Hardik J ^a   Chiosis, Gabriela ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MOLECULAR PROBE;

GENETIC MANIPULATION; HUMAN; NITROSYLATION; OXIDATION; PHYSICAL DISEASE; PROTEIN ACETYLATION; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; UBIQUITINATION; ANALYSIS; ANIMAL; GENETIC PROCEDURES; METABOLISM; MOLECULAR DIAGNOSIS; MOLECULAR MODEL; MOLECULAR PROBE; PROCEDURES;

ANIMALS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES;

EID: 84965057093     PISSN: 24519456     EISSN: 24519448     Source Type: Journal    
DOI: 10.1016/j.chembiol.2015.12.006     Document Type: Review

References (115)

1. J. Abisambra, U.K. Jinwal, Y. Miyata, J. Rogers, L. Blair, X. Li, S.P. Seguin, L. Wang, Y. Jin, J. Bacon, and et al. Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau Biol. Psychiatry 74 2013 367 374
2. C. Adam, A. Baeurle, J.L. Brodsky, P. Wipf, D. Schrama, J.C. Becker, and R. Houben The Hsp70 modulator mal3-101 inhibits Merkel cell carcinoma PLoS One 9 2014 e92041
3. S.V. Alarcon, M. Mollapour, M.J. Lee, S. Tsutsumi, S. Lee, Y.S. Kim, T. Prince, A.B. Apolo, G. Giaccone, W. Xu, and et al. Tumor-intrinsic and tumor-extrinsic factors impacting Hsp90-targeted therapy Curr. Mol. Med. 12 2012 1125 1141
4. D.C. Altieri Mitochondrial Hsp90s and tumor cell metabolism Autophagy 9 2013 244 245
5. G.M. Balaburski, J.I. Leu, N. Beeharry, S. Hayik, M.D. Andrake, G. Zhang, M. Herlyn, J. Villanueva, R.L. Dunbrack Jr., T. Yen, and et al. A modified Hsp70 inhibitor shows broad activity as an anticancer agent Mol. Cancer Res. 11 2013 219 229
6. J.J. Barrott, P.F. Hughes, T. Osada, X.Y. Yang, Z.C. Hartman, D.R. Loiselle, N.L. Spector, L. Neckers, N. Rajaram, F. Hu, and et al. Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells Chem. Biol. 20 2013 1187 1197
7. K. Beebe, M. Mollapour, B. Scroggins, C. Prodromou, W. Xu, M. Tokita, T. Taldone, L. Pullen, B.K. Zierer, M.J. Lee, and et al. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors Oncotarget 4 2013 1065 1074
8. L.K. Boroughs, M.A. Antonyak, J.L. Johnson, and R.A. Cerione A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration J. Biol. Chem. 286 2011 37094 37107
9. O. Bounedjah, B. Desforges, T.D. Wu, C. Pioche-Durieu, S. Marco, L. Hamon, P.A. Curmi, J.L. Guerquin-Kern, O. Pietrement, and D. Pastre Free mRNA in excess upon polysome dissociation is a scaffold for protein multimerization to form stress granules Nucleic Acids Res. 42 2014 8678 8691
10. A. Bracher, and J. Verghese GrpE, Hsp110/Grp170, Hspbp1/sil1 and bag domain proteins: nucleotide exchange factors for Hsp70 molecular chaperones Subcell. Biochem. 78 2015 1 33
11. M.J. Braunstein, S.S. Scott, C.M. Scott, S. Behrman, P. Walter, P. Wipf, J.D. Coplan, W. Chrico, D. Joseph, J.L. Brodsky, and et al. Antimyeloma effects of the heat shock protein 70 molecular chaperone inhibitor MAL3-101 J. Oncol. 2011 2011 232037
12. M. Brehme, C. Voisine, T. Rolland, S. Wachi, J.H. Soper, Y. Zhu, K. Orton, A. Villella, D. Garza, M. Vidal, and et al. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease Cell Rep. 9 2014 1135 1150
13. J.C. Brooks, W. Sun, G. Chiosis, and C.A. Leifer Heat shock protein gp96 regulates toll-like receptor 9 proteolytic processing and conformational stability Biochem. Biophys. Res. Commun. 421 2012 780 784
14. M.C. Caino, Y.C. Chae, V. Vaira, S. Ferrero, M. Nosotti, N.M. Martin, A. Weeraratna, M. O'Connell, D. Jernigan, A. Fatatis, and et al. Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells J. Clin. Invest. 123 2013 2907 2920
15. A. Carman, S. Kishinevsky, J. Koren 3rd, W. Lou, and G. Chiosis Chaperone-dependent neurodegeneration: a molecular perspective on therapeutic intervention J. Alzheimers Dis. Parkinsonism 2013 Suppl 10 2013 10.4172/2161-0460.S10-007 007
16. L.C. Cerchietti, E.C. Lopes, S.N. Yang, K. Hatzi, K.L. Bunting, L.A. Tsikitas, A. Mallik, A.I. Robles, J. Walling, L. Varticovski, and et al. A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas Nat. Med. 15 2009 1369 1376
17. Y.C. Chae, A. Angelin, S. Lisanti, A.V. Kossenkov, K.D. Speicher, H. Wang, J.F. Powers, A.S. Tischler, K. Pacak, S. Fliedner, and et al. Landscape of the mitochondrial Hsp90 metabolome in tumours Nat. Commun. 4 2013 2139
18. Y. Chiba, T. Kubota, M. Watanabe, Y. Otani, T. Teramoto, Y. Matsumoto, K. Koya, and M. Kitajima Selective antitumor activity of MKT-077, a delocalized lipophilic cation, on normal cells and cancer cells in vitro J. Surg. Oncol. 69 1998 105 110
19. G. Chiosis, M.N. Timaul, B. Lucas, P.N. Munster, F.F. Zheng, L. Sepp-Lorenzino, and N. Rosen A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells Chem. Biol. 8 2001 289 299
20. H.J. Cho, H.Y. Gee, K.H. Baek, S.K. Ko, J.M. Park, H. Lee, N.D. Kim, M.G. Lee, and I. Shin A small molecule that binds to an ATPase domain of Hsc70 promotes membrane trafficking of mutant cystic fibrosis transmembrane conductance regulator J. Am. Chem. Soc. 133 2011 20267 20276
21. H.S. Cho, T. Shimazu, G. Toyokawa, Y. Daigo, Y. Maehara, S. Hayami, A. Ito, K. Masuda, N. Ikawa, H.I. Field, and et al. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B Nat. Commun. 3 2012 1072
22. T.A. Colvin, V.L. Gabai, J. Gong, S.K. Calderwood, H. Li, S. Gummuluru, O.N. Matchuk, S.G. Smirnova, N.V. Orlova, I.A. Zamulaeva, and et al. Hsp70-bag3 interactions regulate cancer-related signaling networks Cancer Res. 74 2014 4731 4740
23. P. Connell, C.A. Ballinger, J. Jiang, Y. Wu, L.J. Thompson, J. Hohfeld, and C. Patterson The co-chaperone Chip regulates protein triage decisions mediated by heat-shock proteins Nat. Cell. Biol. 3 2001 93 96
24. M. Daugaard, M. Rohde, and M. Jaattela The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions FEBS Lett. 581 2007 3702 3710
25. M.R. Defee, Z. Qin, L. Dai, B.P. Toole, J.S. Isaacs, and C.H. Parsons Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus Am. J. Cancer Res. 1 2011 687 700
26. A.S. Duerfeldt, L.B. Peterson, J.C. Maynard, C.L. Ng, D. Eletto, O. Ostrovsky, H.E. Shinogle, D.S. Moore, Y. Argon, C.V. Nicchitta, and et al. Development of a Grp94 inhibitor J. Am. Chem. Soc. 134 2012 9796 9804
27. J.T. Ernst, T. Neubert, M. Liu, S. Sperry, H. Zuccola, A. Turnbull, B. Fleck, W. Kargo, L. Woody, P. Chiang, and et al. Identification of novel Hsp90alpha/beta isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease J. Med. Chem. 57 2014 3382 3400
28. S.W. Fewell, C.M. Smith, M.A. Lyon, T.P. Dumitrescu, P. Wipf, B.W. Day, and J.L. Brodsky Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity J. Biol. Chem. 279 2004 51131 51140
29. A. Finka, and P. Goloubinoff Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis Cell Stress Chaperones 18 2013 591 605
30. R. Geller, S. Taguwa, and J. Frydman Broad action of Hsp90 as a host chaperone required for viral replication Biochim. Biophys. Acta 1823 2012 698 706
31. R.L. Goldstein, S.N. Yang, T. Taldone, B. Chang, J. Gerecitano, K. Elenitoba-Johnson, R. Shaknovich, W. Tam, J.P. Leonard, G. Chiosis, and et al. Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma J. Clin. Invest. 2015 2015 10.1172/JCI80714
32. M. Granato, V. Lacconi, M. Peddis, L.V. Lotti, L. Di Renzo, R. Gonnella, R. Santarelli, P. Trivedi, L. Frati, G. D'orazi, and et al. Hsp70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma Cell Death Dis. 4 2013 e730
33. J.A. Hall, L.K. Forsberg, and B.S. Blagg Alternative approaches to Hsp90 modulation for the treatment of cancer Future Med. Chem. 6 2014 1587 1605
34. F.U. Hartl, A. Bracher, and M. Hayer-Hartl Molecular chaperones in protein folding and proteostasis Nature 475 2011 324 332
35. M.P. Hernandez, W.P. Sullivan, and D.O. Toft The assembly and intermolecular properties of the Hsp70-Hop-Hsp90 molecular chaperone complex J. Biol. Chem. 277 2002 38294 38304
36. F. Hong, B. Liu, G. Chiosis, D.T. Gewirth, and Z. Li Alpha 7 helix region of alpha I domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis J. Biol. Chem. 288 2013 18243 18248
37. Y. Hua, S. White-Gilbertson, J. Kellner, S. Rachidi, S.Z. Usmani, G. Chiosis, R. Depinho, Z. Li, and B. Liu Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma Clin. Cancer Res. 19 2013 6242 6251
38. T. Imai, Y. Kato, C. Kajiwara, S. Mizukami, I. Ishige, T. Ichiyanagi, M. Hikida, J.Y. Wang, and H. Udono Heat shock protein 90 (Hsp90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells Proc. Natl. Acad. Sci. USA 108 2011 16363 16368
39. K. Jhaveri, S.O. Ochiana, M.P. Dunphy, J.F. Gerecitano, A.D. Corben, R.I. Peter, Y.Y. Janjigian, E.M. Gomes-Dagama, J. Koren 3rd, S. Modi, and et al. Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions Expert Opin. Investig. Drugs 23 2014 611 628
40. A. Kamal, L. Thao, J. Sensintaffar, L. Zhang, M.F. Boehm, L.C. Fritz, and F.J. Burrows A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Nature 425 2003 407 410
41. H.H. Kampinga, and E.A. Craig The Hsp70 chaperone machinery: J proteins as drivers of functional specificity Nat. Rev. Mol. Cell Biol. 11 2010 579 592
42. B.H. Kang, J. Plescia, H.Y. Song, M. Meli, G. Colombo, K. Beebe, B. Scroggins, L. Neckers, and D.C. Altieri Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90 J. Clin. Invest. 119 2009 454 464
43. Y.E. Kim, M.S. Hipp, A. Bracher, M. Hayer-Hartl, and F.U. Hartl Molecular chaperone functions in protein folding and proteostasis Annu. Rev. Biochem. 82 2013 323 355
44. R. Kityk, J. Kopp, I. Sinning, and M.P. Mayer Structure and dynamics of the ATP-bound open conformation of Hsp70 chaperones Mol. Cell 48 2012 863 874
45. S.K. Ko, J. Kim, D.C. Na, S. Park, S.H. Park, J.Y. Hyun, K.H. Baek, N.D. Kim, N.K. Kim, Y.N. Park, and et al. A small molecule inhibitor of ATPase activity of Hsp70 induces apoptosis and has antitumor activities Chem. Biol. 22 2015 391 403
46. K. Koya, Y. Li, H. Wang, T. Ukai, N. Tatsuta, M. Kawakami, Shishido, and L.B. Chen Mkt-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation Cancer Res. 56 1996 538 543
47. K.A. Krukenberg, T.O. Street, L.A. Lavery, and D.A. Agard Conformational dynamics of the molecular chaperone Hsp90 Q. Rev. Biophys. 44 2011 229 255
48. C. Lee, H.K. Park, H. Jeong, J. Lim, A.J. Lee, K.Y. Cheon, C.S. Kim, A.P. Thomas, B. Bae, N.D. Kim, and et al. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1 J. Am. Chem. Soc. 137 2015 4358 4367
49. J.I.J. Leu, J. Pimkina, A. Frank, M.E. Murphy, and D.L. George A small molecule inhibitor of inducible heat shock protein 70 Mol. Cell 36 2009 15 27
50. J.I.J. Leu, J. Pimkina, P. Pandey, M.E. Murphy, and D.L. George Hsp70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells Mol. Cancer Res. 9 2011 936 947
51. J. Li, J. Soroka, and J. Buchner The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones Biochim. Biophys. Acta 1823 2012 624 635
52. X. Li, T. Colvin, J.N. Rauch, D. Acosta-Alvear, M. Kampmann, B. Dunyak, B. Hann, B.T. Aftab, M. Murnane, M. Cho, and et al. Validation of the Hsp70-bag3 protein-protein interaction as a potential therapeutic target in cancer Mol. Cancer Ther. 14 2015 642 648
53. X. Li, L. Sun, J. Hou, M. Gui, J. Ying, H. Zhao, N. Lv, and S. Meng Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer Int. J. Cancer 137 2015 512 524
54. S. Lisanti, M. Tavecchio, Y.C. Chae, Q. Liu, A.K. Brice, M.L. Thakur, L.R. Languino, and D.C. Altieri Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks Cell Rep. 8 2014 671 677
55. Y.V. Lyupina, O.V. Orlova, S.B. Abaturova, S.N. Beljelarskaya, A.N. Lavrov, and V.S. Mikhailov Egress of budded virions of Autographa californica nucleopolyhedrovirus does not require activity of Spodoptera frugiperda HSP/HSC70 chaperones Virus Res. 192 2014 1 5
56. A.T. Macias, D.S. Williamson, N. Allen, J. Borgognoni, A. Clay, Z. Daniels, P. Dokurno, M.J. Drysdale, G.L. Francis, C.J. Graham, and et al. Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity J. Med. Chem. 54 2011 4034 4041
57. M. Marzec, D. Eletto, and Y. Argon Grp94: an Hsp90-like protein specialized for protein folding and quality control in the endoplasmic reticulum Biochim. Biophys. Acta 1823 2012 774 787
58. A.J. Massey, D.S. Williamson, H. Browne, J.B. Murray, P. Dokurno, T. Shaw, A.T. Macias, Z. Daniels, S. Geoffroy, M. Dopson, and et al. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells Cancer Chemother. Pharmacol. 66 2010 535 545
59. P. Mattiolo, A. Barbero-Farran, J. Amigo, M. Ripamonti, J. Ribas, and J. Boix Cell death induced by 2-phenylethynesulfonamide uncovers a pro-survival function of BAX Cancer Lett. 354 2014 115 121
60. R.L. Matts, G.E. Brandt, Y. Lu, A. Dixit, M. Mollapour, S. Wang, A.C. Donnelly, L. Neckers, G. Verkhivker, and B.S. Blagg A systematic protocol for the characterization of Hsp90 modulators Bioorg. Med. Chem. 19 2011 684 692
61. M.P. Mayer, and B. Bukau Hsp70 chaperones: cellular functions and molecular mechanism Cell Mol. Life Sci. 62 2005 670 684
62. M.P. Mayer, and R. Kityk Insights into the molecular mechanism of allostery in Hsp70s Front. Mol. Biosci. 2 2015 58
63. J. McCready, D.S. Wong, J.A. Burlison, W. Ying, and D.G. Jay An impermeant ganetespib analog inhibits extracellular Hsp90-mediated cancer cell migration that involves lysyl oxidase 2-like protein Cancers (Basel) 6 2014 1031 1046
64. M. Mollapour, and L. Neckers Post-translational modifications of Hsp90 and their contributions to chaperone regulation Biochim. Biophys. Acta 1823 2012 648 655
65. M. Mollapour, D. Bourboulia, K. Beebe, M.R. Woodford, S. Polier, A. Hoang, R. Chelluri, Y. Li, A. Guo, M.J. Lee, and et al. Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors Mol. Cell 53 2014 317 329
66. H. Monma, N. Harashima, T. Inao, S. Okano, Y. Tajima, and M. Harada The Hsp70 and autophagy inhibitor pifithrin-mu enhances the antitumor effects of trail on human pancreatic cancer Mol. Cancer Ther. 12 2013 341 351
67. K. Moulick, J.H. Ahn, H. Zong, A. Rodina, L. Cerchietti, E.M. Gomes Dagama, E. Caldas-Lopes, K. Beebe, F. Perna, K. Hatzi, and et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 Nat. Chem. Biol. 7 2011 818 826
68. P. Muller, E. Ruckova, P. Halada, P.J. Coates, R. Hrstka, D.P. Lane, and B. Vojtesek C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones Chip and Hop to determine cellular protein folding/degradation balances Oncogene 32 2013 3101 3110
69. U. Nayar, P. Lu, R.L. Goldstein, J. Vider, G. Ballon, A. Rodina, T. Taldone, H. Erdjument-Bromage, M. Chomet, R. Blasberg, and et al. Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies Blood 122 2013 2837 2847
70. L. Neckers Chaperoning oncogenes: Hsp90 as a target of geldanamycin Handb. Exp. Pharmacol. 2006 259 277
71. L. Neckers, T.W. Schulte, and E. Mimnaugh Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity Invest. New Drugs 17 1999 361 373
72. L. O'Regan, J. Sampson, M.W. Richards, A. Knebel, D. Roth, F.E. Hood, A. Straube, S.J. Royle, R. Bayliss, and A.M. Fry Hsp72 is targeted to the mitotic spindle by nek6 to promote k-fiber assembly and mitotic progression J. Cell Biol. 209 2015 349 358
73. H.K. Park, J.E. Lee, J. Lim, and B.H. Kang Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells Mol. Cancer 13 2014 148
74. H.J. Patel, S. Modi, G. Chiosis, and T. Taldone Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment Expert Opin. Drug Discov. 6 2011 559 587
75. P.D. Patel, P. Yan, P.M. Seidler, H.J. Patel, W. Sun, C. Yang, N.S. Que, T. Taldone, P. Finotti, R.A. Stephani, and et al. Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2 Nat. Chem. Biol. 9 2013 677 684
76. H.J. Patel, P.D. Patel, S.O. Ochiana, P. Yan, W. Sun, M.R. Patel, S.K. Shah, E. Tramentozzi, J. Brooks, A. Bolaender, and et al. Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94 J. Med. Chem. 58 2015 3922 3943
77. G. Pimienta, K.M. Herbert, and L. Regan A compound that inhibits the Hop-Hsp90 complex formation and has unique killing effects in breast cancer cell lines Mol. Pharm. 8 2011 2252 2261
78. W.B. Pratt, J.E. Gestwicki, Y. Osawa, and A.P. Lieberman Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases Annu. Rev. Pharmacol. Toxicol. 55 2015 353 371
79. T.L. Prince, T. Kijima, M. Tatokoro, S. Lee, S. Tsutsumi, K. Yim, C. Rivas, S. Alarcon, H. Schwartz, K. Khamit-Kush, and et al. Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced Hsp90 isoforms and their conformationally restricted mutants PLoS One 10 2015 e0141786
80. C. Prodromou The 'active life' of Hsp90 complexes Biochim. Biophys. Acta 1823 2012 614 623
81. S. Qin, M. Ni, X. Wang, F. Maurier-Mahe, D.L. Shurland, and G.A. Rodrigues Inhibition of RPE cell sterile inflammatory responses and endotoxin-induced uveitis by a cell-impermeable Hsp90 inhibitor Exp. Eye Res. 93 2011 889 897
82. A. Rodina, M. Vilenchik, K. Moulick, J. Aguirre, J. Kim, A. Chiang, J. Litz, C.C. Clement, Y. Kang, Y. She, and et al. Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer Nat. Chem. Biol. 3 2007 498 507
83. A. Rodina, P.D. Patel, Y. Kang, Y. Patel, I. Baaklini, M.J. Wong, T. Taldone, P. Yan, C. Yang, R. Maharaj, and et al. Identification of an allosteric pocket on human Hsp70 reveals a mode of inhibition of this therapeutically important protein Chem. Biol. 20 2013 1469 1480
84. A. Rodina, T. Taldone, Y. Kang, P.D. Patel, J. Koren 3rd, P. Yan, E.M. Dagama Gomes, C. Yang, M.R. Patel, L. Shrestha, and et al. Affinity purification probes of potential use to investigate the endogenous Hsp70 interactome in cancer ACS Chem. Biol. 9 2014 1698 1705
85. M.F. Rosser, and C.V. Nicchitta Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, Grp94. I. Evidence for allosteric regulation of ligand binding J. Biol. Chem. 275 2000 22798 22805
86. A. Rousaki, Y. Miyata, U.K. Jinwal, C.A. Dickey, J.E. Gestwicki, and E.R. Zuiderweg Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones J. Mol. Biol. 411 2011 614 632
87. S.L. Rutherford, and S. Lindquist Hsp90 as a capacitor for morphological evolution Nature 396 1998 336 342
88. R.S. Samant, P.A. Clarke, and P. Workman The expanding proteome of the molecular chaperone Hsp90 Cell Cycle 11 2012 1301 1308
89. T.A. Sangster, S. Lindquist, and C. Queitsch Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance Bioessays 26 2004 348 362
90. F. Santos, M. Nequiz, N.A. Hernandez-Cuevas, K. Hernandez, E. Pineda, R. Encalada, N. Guillen, E. Luis-Garcia, A. Saralegui, E. Saavedra, and et al. Maintenance of intracellular hypoxia and adequate heat shock response are essential requirements for pathogenicity and virulence of Entamoeba histolytica Cell Microbiol. 17 2015 1037 1051
91. E. Schmitt, L. Maingret, P.E. Puig, A.L. Rerole, F. Ghiringhelli, A. Hammann, E. Solary, G. Kroemer, and C. Garrido Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma Cancer Res. 66 2006 4191 4197
92. M. Sevin, F. Girodon, C. Garrido, and A. De Thonel Hsp90 and Hsp70: implication in inflammation processes and therapeutic approaches for myeloproliferative neoplasms Mediators Inflamm. 2015 2015 970242
93. K. Sharma, R.M. Vabulas, B. Macek, S. Pinkert, J. Cox, M. Mann, and F.U. Hartl Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response Mol. Cell Proteomics 11 2012 M111 014654
94. M.Y. Sherman, and V.L. Gabai Hsp70 in cancer: back to the future Oncogene 34 2015 4153 4161
95. K.L. Soldano, A. Jivan, C.V. Nicchitta, and D.T. Gewirth Structure of the N-terminal domain of Grp94. Basis for ligand specificity and regulation J. Biol. Chem. 278 2003 48330 48338
96. C.E. Stebbins, A.A. Russo, C. Schneider, N. Rosen, F.U. Hartl, and N.P. Pavletich Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent Cell 89 1997 239 250
97. A.R. Stothert, A. Suntharalingam, D.J. Huard, S.N. Fontaine, V.M. Crowley, S. Mishra, B.S. Blagg, R.L. Lieberman, and C.A. Dickey Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma Hum. Mol. Genet. 23 2014 6470 6480
98. T.O. Street, L.A. Lavery, and D.A. Agard Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone Mol. Cell 42 2011 96 105
99. A. Suntharalingam, J.F. Abisambra, J.C. O'Leary 3rd, J. Koren 3rd, B. Zhang, M.K. Joe, L.J. Blair, S.E. Hill, U.K. Jinwal, M. Cockman, and et al. Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism J. Biol. Chem. 287 2012 40661 40669
100. T. Taldone, E.M. Gomes-Dagama, H. Zong, S. Sen, M.L. Alpaugh, D. Zatorska, R. Alonso-Sabadell, M.L. Guzman, and G. Chiosis Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy Bioorg. Med. Chem. Lett. 21 2011 5347 5352
101. T. Taldone, P.D. Patel, M. Patel, H.J. Patel, C.E. Evans, A. Rodina, S. Ochiana, S.K. Shah, M. Uddin, D. Gewirth, and et al. Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series J. Med. Chem. 56 2013 6803 6818
102. T. Taldone, A. Rodina, E.M. Dagama Gomes, M. Riolo, H.J. Patel, R. Alonso-Sabadell, D. Zatorska, M.R. Patel, S. Kishinevsky, and G. Chiosis Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes Beilstein J. Org. Chem. 9 2013 544 556
103. T. Taldone, Y. Kang, H.J. Patel, M.R. Patel, P.D. Patel, A. Rodina, Y. Patel, A. Gozman, R. Maharaj, C.C. Clement, and et al. Heat shock protein 70 inhibitors. 2. 2,5′-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70 J. Med. Chem. 57 2014 1208 1224
104. T. Taldone, S.O. Ochiana, P.D. Patel, and G. Chiosis Selective targeting of the stress chaperome as a therapeutic strategy Trends Pharmacol. Sci. 35 2014 592 603
105. P.A. Tsaytler, J. Krijgsveld, S.S. Goerdayal, S. Rudiger, and M.R. Egmond Novel Hsp90 partners discovered using complementary proteomic approaches Cell Stress Chaperones 14 2009 629 638
106. S. Tsutsumi, and L. Neckers Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis Cancer Sci. 98 2007 1536 1539
107. S. Tsutsumi, B. Scroggins, F. Koga, M.J. Lee, J. Trepel, S. Felts, C. Carreras, and L. Neckers A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion Oncogene 27 2008 2478 2487
108. C.K. Vaughan, M. Mollapour, J.R. Smith, A. Truman, B. Hu, V.M. Good, B. Panaretou, L. Neckers, P.A. Clarke, P. Workman, and et al. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37 Mol. Cell 31 2008 886 895
109. A.M. Wang, Y. Miyata, S. Klinedinst, H.M. Peng, J.P. Chua, T. Komiyama, X. Li, Y. Morishima, D.E. Merry, W.B. Pratt, and et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation Nat. Chem. Biol. 9 2013 112 118
110. L. Whitesell, E.G. Mimnaugh, B. De Costa, C.E. Myers, and L.M. Neckers Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation Proc. Natl. Acad. Sci. USA 91 1994 8324 8328
111. L. Whitesell, S. Santagata, M.L. Mendillo, N.U. Lin, D.A. Proia, and S. Lindquist Hsp90 empowers evolution of resistance to hormonal therapy in human breast cancer models Proc. Natl. Acad. Sci. USA 111 2014 18297 18302
112. D.R. Williams, S.K. Ko, S. Park, M.R. Lee, and I. Shin An apoptosis-inducing small molecule that binds to heat shock protein 70 Angew. Chem. Int. Ed. Engl. 47 2008 7466 7469
113. S. Wisen, E.B. Bertelsen, A.D. Thompson, S. Patury, P. Ung, L. Chang, C.G. Evans, G.M. Walter, P. Wipf, H.A. Carlson, and et al. Binding of a small molecule at a protein-protein interface regulates the chaperone activity of Hsp70-Hsp40 ACS Chem. Biol. 5 2010 611 622
114. W. Xu, and L. Neckers Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells Clin. Cancer Res. 13 2007 1625 1629
115. W. Xu, M. Mollapour, C. Prodromou, S. Wang, B.T. Scroggins, Z. Palchick, K. Beebe, M. Siderius, M.J. Lee, A. Couvillon, and et al. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine Mol. Cell 47 2012 434 443